Stallion Platinum 30000 Capsules (Motto International) - Undeclared Tadalafil (2019)
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death
Class I recall indicates potential for serious health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
Brand
Motto International Corp
Lot Codes / Batch Numbers
All lots remaining within expiry.
Products Sold
All lots remaining within expiry.
Motto International Corp is recalling Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram pap due to Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
TX
Page updated: Jan 7, 2026